Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LEVINE EOSIN METHYLENE BLUE AGAR

K-Number: K841751 · 1984-05-31

ApplicantThe Montana Deaconess Medical Center
Decision Date1984-05-31
Product CodeJSI
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

LEVINE EOSIN METHYLENE BLUE AGAR is the device name listed in this FDA 510(k) record. The listed applicant is The Montana Deaconess Medical Center. It received FDA 510(k) clearance on 1984-05-31 under 510(k) number K841751. The device is classified under product code JSI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LEVINE EOSIN METHYLENE BLUE AGAR?

LEVINE EOSIN METHYLENE BLUE AGAR is a medical device that received FDA 510(k) clearance on 1984-05-31. The listed applicant is The Montana Deaconess Medical Center. The 510(k) number is K841751.

When did LEVINE EOSIN METHYLENE BLUE AGAR receive FDA 510(k) clearance?

LEVINE EOSIN METHYLENE BLUE AGAR received FDA 510(k) clearance on 1984-05-31, under 510(k) number K841751.

Who is the listed applicant for LEVINE EOSIN METHYLENE BLUE AGAR?

The FDA 510(k) record lists The Montana Deaconess Medical Center as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LEVINE EOSIN METHYLENE BLUE AGAR?

The FDA product code for LEVINE EOSIN METHYLENE BLUE AGAR is JSI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing The Montana Deaconess Medical Center as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K841752XYLOSE-LYSINE DESOXYCHOLATE AGARK841753MACCONKEY AGARK841747MANNITOL SALT AGARK841750MARTIN-LEWIS AGARK841748SHEEP BLOOD AGARK841749CHOCOLATE AGAR

View all 11 devices →

Related Devices (Code: JSI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K070691BBL CHROMAGAR 0157Becton, Dickinson & COK974428DIPSTREAKNovamed , Ltd.K891593LISTERIA SELECTIVE ENRICHMENT MEDIUMOxoid U.S.A., Inc.K890199DENTOCULT SM-STRIP MUTANSOrion Corp.K882182SALMONELLA-SHIGELLA (SS) AGAR - PRODUCT #P3326Lakewood Biochemical Co., Inc.K881575SELECTIVE STREPTOCOCCUS AGARAcumedia Manufacturers, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑